Approval · Notice of Compliance 7779 · 2006
RITALIN: Notice of Compliance 7779
Issued February 22, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7779
- Date
- February 22, 2006
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
- Therapeutic class
- Cns stimulant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RITALIN | Not yet assigned | — |
| RITALIN SR | Not yet assigned | — |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 10 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 20 MG per TAB